Jämför metoder

	PedMIDAS	PedsQL Diabetesmodul	Quality of Life in Childhood Epilepsy (QOLCE)
Ämnesområde	Pediatrik	Pediatrik	Pediatrik
Familj	Process / pipeline	Process / pipeline	Process / pipeline
Ursprungsår	2001	2003	2000
Upphovsperson	Amy D. Hershey	James W. Varni	Mark Sabaz
Typ	Parent-report and/or child self-report of missed activities	Child self-report and parent proxy	Parent report; child self-report version available
Ursprungskälla	Hershey, A. D., Powers, S. W., Vockell, A. L., LeCates, S., & Ellinwood, E. H. (2001). PedMIDAS: Development of a questionnaire to assess disabilities in migrainous children. Headache, 41(6), 556-563.	Varni, J. W., Burwinkle, T. M., Jacobs, J. R., Gottschalk, M., Kaufman, F., & Jones, K. L. (2003). The PedsQL in type 1 and type 2 diabetes: Reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales and type 1 Diabetes Module. Diabetes Care, 26(3), 631-637.	Sabaz, M., Cairns, D. R., Lah, S., Williams, B., Gurrin, L., Connelly, A., & Berkovic, S. F. (2000). Validation of the Quality of Life in Childhood Epilepsy Questionnaire in Australian children with newly diagnosed and chronic epilepsy. Neurology, 55(9), 1646-1652.
Alias	Pediatric Migraine Disability Assessment, MIDAS, MIDAS Pediatric	PedsQL 3.0 Diabetes	QOL in Childhood Epilepsy Questionnaire
Närliggande	4	5	4
Sammanfattning	The PedMIDAS is a brief 6-item parent-report (with child input for older youth) instrument developed by Hershey et al. in 2001 to quantify migraine-related functional disability in children and adolescents. Rather than measuring pain intensity or headache frequency, the PedMIDAS focuses on the ultimate impact of migraine on daily life: how many days of school, sports/play, and family activities does the child miss or participate in only with significant limitation? This outcome-focused approach makes it particularly useful for assessing the real-world burden of migraine in children and evaluating treatment effectiveness.	The PedsQL Diabetes Module is a 28-item disease-specific instrument developed by Varni et al. in 2003 to measure quality of life in children and adolescents with type 1 and type 2 diabetes. It captures the impact of diabetes management, glucose monitoring, and disease-related worry on daily functioning. The module is paired with the PedsQL Generic Core Scales, enabling both disease-specific and general health-related quality of life assessment.	The QOLCE is a comprehensive 76-item disease-specific instrument developed by Sabaz et al. in 2000 to assess quality of life in children with epilepsy aged 4–16 years. Measuring across 16 distinct domains including seizure worry, cognitive concerns, medication effects, school/peer functioning, and family impact, the QOLCE provides a nuanced profile of how epilepsy and its treatment affect daily life. It exists in parent-report (QOLCE-P) and child self-report (QOLCE-C) versions.